Rapamycin Augmentation of Chronic Ketamine as a Novel Treatment for Complex Regional Pain Syndrome.

Rapamycin Augmentation of Chronic Ketamine as a Novel Treatment for Complex Regional Pain Syndrome.
复制标题

雷帕霉素增强慢性氯胺酮作为复杂区域疼痛综合征的新型治疗方法。

DOI:
10.7759/cureus.43715
复制
发表时间:
2023-08
期刊:
Cureus
影响因子:
--
通讯作者:
Berner J
Berner J
中科院分区:
其他
文献类型:
--
作者:
Sharma A;Tajerian M;Berner J

文献摘要

参考文献

相似文献

本病例报告描述了难治性慢性复杂性局部疼痛综合征对联合免疫调节治疗的显著临床反应。氯胺酮和雷帕霉素显著减少了与自杀行为相关的疼痛,增加了基线活动,并减少了姑息性多药治疗。考虑到多个假定的靶点,如小胶质细胞、星形胶质细胞、T调节细胞、B调节细胞或神经元,分段作用机制尚不清楚。相关的实验室和遗传信息可能允许将这种治疗应用于其他受影响的个体。
This case report describes the dramatic clinical response of refractory chronic complex regional pain syndrome to combined immunomodulatory treatment. Ketamine and rapamycin markedly minimized pain historically associated with suicidal behavior, increased baseline activity, and allowed for a reduction in palliative polypharmacy. The piecewise mechanism of action is unclear given multiple postulated targets, such as microglia, astroglia, T-regulatory cells, B-regulatory cells, or neurons. Relevant laboratory and genetic information may allow the application of this treatment to other affected individuals.
DOI: 10.1016/j.cellimm.2018.09.008
发表时间: 2019-05-01
影响因子: 4.3
作者:
Kumar, Prabhakaran;Saini, Shikha;Prabhakar, Bellur S.
通讯作者: Prabhakar, Bellur S.
DOI: 10.1093/bja/aem218
发表时间: 2007-10-01
影响因子: 9.8
作者:
Beilin, B.;Rusabrov, Y.;Bessler, H.
通讯作者: Bessler, H.
DOI: 10.1097/j.pain.0000000000001765
发表时间: 2020-04-01
期刊: PAIN
影响因子: 7.4
作者:
Guo, Tian-Zhi;Wei, Tzuping;Kingery, Wade S.
通讯作者: Kingery, Wade S.
DOI: 10.15252/embr.202051981
发表时间: 2021-09-06
期刊: EMBO reports
影响因子: 7.7
作者:
Menga A;Favia M;Spera I;Vegliante MC;Gissi R;De Grassi A;Laera L;Campanella A;Gerbino A;Carrà G;Canton M;Loizzi V;Pierri CL;Cormio G;Mazzone M;Castegna A
通讯作者: Castegna A
DOI: 10.1016/j.transproceed.2006.10.065
发表时间: 2006-12-01
影响因子: 0.9
作者:
Grim, S. A.;Slover, C. M.;Clark, N. M.
通讯作者: Clark, N. M.